143 related articles for article (PubMed ID: 27504133)
1. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience.
Lim TY; Kudchadker RJ; Wang J; Bathala T; Szklaruk J; Pugh TJ; Mahmood U; Ibbott GS; Frank SJ
J Contemp Brachytherapy; 2016 Jun; 8(3):235-42. PubMed ID: 27504133
[TBL] [Abstract][Full Text] [Related]
2. Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment.
Lim TY; Kudchadker RJ; Wang J; Stafford RJ; MacLellan C; Rao A; Ibbott GS; Frank SJ
Med Phys; 2016 Jul; 43(7):4312. PubMed ID: 27370146
[TBL] [Abstract][Full Text] [Related]
3. Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy.
Ma J; Moerland MA; Venkatesan AM; Bathala TK; Kudchadker RJ; Brock KK; Frank SJ
Brachytherapy; 2017; 16(4):743-753. PubMed ID: 28063817
[TBL] [Abstract][Full Text] [Related]
4. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA
Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857
[TBL] [Abstract][Full Text] [Related]
5. MRI-based automated detection of implanted low dose rate (LDR) brachytherapy seeds using quantitative susceptibility mapping (QSM) and unsupervised machine learning (ML).
Nosrati R; Soliman A; Safigholi H; Hashemi M; Wronski M; Morton G; Pejović-Milić A; Stanisz G; Song WY
Radiother Oncol; 2018 Dec; 129(3):540-547. PubMed ID: 30243670
[TBL] [Abstract][Full Text] [Related]
6. SU-D-213CD-05: Identifying Prostate Brachytherapy Seeds at MRI: A Study in Phantom.
Fatemi-Ardekani A; Borg J
Med Phys; 2012 Jun; 39(6Part3):3618. PubMed ID: 28517405
[TBL] [Abstract][Full Text] [Related]
7. The applicability of simultaneous TRUS-CT imaging for the evaluation of prostate seed implants.
Steggerda M; Schneider C; van Herk M; Zijp L; Moonen L; van der Poel H
Med Phys; 2005 Jul; 32(7Part1):2262-2270. PubMed ID: 28493573
[TBL] [Abstract][Full Text] [Related]
8. Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.
Watanabe K; Katayama N; Katsui K; Matsushita T; Takamoto A; Ihara H; Nasu Y; Takemoto M; Kuroda M; Kanazawa S
J Radiat Res; 2019 Jul; 60(4):483-489. PubMed ID: 31083713
[TBL] [Abstract][Full Text] [Related]
9. Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.
Martin GV; Pugh TJ; Mahmood U; Kudchadker RJ; Wang J; Bruno TL; Bathala T; Blanchard P; Frank SJ
Brachytherapy; 2017; 16(4):761-769. PubMed ID: 28501429
[TBL] [Abstract][Full Text] [Related]
10. MRI of prostate brachytherapy seeds at high field: a study in phantom.
Thomas SD; Wachowicz K; Fallone BG
Med Phys; 2009 Nov; 36(11):5228-34. PubMed ID: 19994533
[TBL] [Abstract][Full Text] [Related]
11. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
[TBL] [Abstract][Full Text] [Related]
12. A new two-step accurate CT-MRI fusion technique for post-implant prostate cancer.
Kunogi H; Hojo H; Wakumoto Y; Saito AI; Ishikura S; Yamashiro Y; Kuwatsuru R; Sasai K
J Contemp Brachytherapy; 2015 Apr; 7(2):117-21. PubMed ID: 26034491
[TBL] [Abstract][Full Text] [Related]
13. Postimplant Dosimetry of Permanent Prostate Brachytherapy: Comparison of MRI-Only and CT-MRI Fusion-Based Workflows.
Nosrati R; Wronski M; Tseng CL; Chung H; Pejović-Milić A; Morton G; Stanisz GJ
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):206-215. PubMed ID: 31627178
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
15. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
[TBL] [Abstract][Full Text] [Related]
17. Sci-Sat AM(2): Brachy-06: A Comparison of MR/CT fusion versus CT alone for assessment of implant quality in permanent prostate brachytherapy.
Sasaki DK; Malkoske K; Bews J; Cho P; Drachenberg D; Chowdhury A
Med Phys; 2008 Jul; 35(7Part3):3417. PubMed ID: 28512893
[TBL] [Abstract][Full Text] [Related]
18. EM-enhanced US-based seed detection for prostate brachytherapy.
Dehghan E; Bharat S; Kung C; Bonillas A; Beaulieu L; Pouliot J; Kruecker J
Med Phys; 2018 Jun; 45(6):2357-2368. PubMed ID: 29604086
[TBL] [Abstract][Full Text] [Related]
19. Post-implant computed tomography-magnetic resonance prostate image registration using feature line parallelization and normalized mutual information.
Vidakovic S; Jans HS; Alexander A; Sloboda RS
J Appl Clin Med Phys; 2006 Jul; 8(1):21-32. PubMed ID: 17592452
[TBL] [Abstract][Full Text] [Related]
20. American College of Radiology-Compliant Short Protocol Breast MRI for High-Risk Breast Cancer Screening: A Prospective Feasibility Study.
Dogan BE; Scoggins ME; Son JB; Wei W; Candelaria R; Yang WT; Ma J
AJR Am J Roentgenol; 2018 Jan; 210(1):214-221. PubMed ID: 29091003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
